Use of unsaturated sphingosine compounds as chemotherapeutic agents for the treatment of cancer
US8741967B2 · kind B2 · utility
0Cited by
2References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 12, 2008 |
| Grant date | Jun 3, 2014 |
| Priority date | — |
| Expiry date | Jun 18, 2030 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to unsaturated sphingosine compounds which are useful as therapeutic agents for the treatment of cancer and for the treatment of other diseases including diabetes and infection with intracellular bacteria. This invention is also directed to methods of using the compounds and pharmaceutical compositions comprising the compounds in treating these diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.